Tag: Emcure Pharmaceuticals Turnover

Emcure Pharmaceuticals Limited is a Non-govt company, incorporated on 16 Apr, 1981. It's a public unlisted company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 20000.0... Read More

Emcure Pharmaceuticals Limited has filed its draft IPO (Initial Public Offering) papers with capital markets regulator SEBI. The company is looking to raise more than Rs 1,100 crore through the... Read More

Emcure Pharmaceuticals Ltd. has a diversified revenue profile, with 44% revenue from India, 31% from U.S./Canada, and 12% from Europe. Apart from an established market position (ranked 12th) in IPM,... Read More

Pune-based Emcure Pharmaceuticals, one of India’s biggest unlisted pharma companies, filed its draft red herring prospectus (DRHP) with the market regulator Sebi on Thursday to raise money through an initial... Read More

Emcure Pharmaceuticals, one of the leading pharma companies in India, has filed papers with markets regulator SEBI to raise funds via an initial public offer (IPO). It will list the... Read More

Emcure Pharmaceuticals Limited has filed its Draft Red Hearing Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI). The company plans to raise funds through the initial public... Read More

Bain Capital-backed Emcure Pharmaceuticals has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial share sale.The initial public offering (IPO) comprises fresh issuance of equity... Read More

India's Emcure Pharmaceuticals has filed draft papers with the market regulator for an initial public offering, a filing showed, making it the latest company to tap capital markets in a... Read More

Bain Capital-backed Emcure Pharmaceuticals filed preliminary papers with capital markets regulator SEBI to raise funds through an initial share sale. The initial public offering comprises fresh issuance of equity shares worth... Read More

Emcure Pharmaceuticals Limited, one of India's biggest pharmaceutical businesses, has filed its Draft Red Hearing Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) to raise funds... Read More